Adenia Partners acquires Parkville Pharmaceuticals Egypt

Adenia Partners agreed to acquire Parkville Pharmaceuticals Egypt. Reported deal value: Undisclosed. Status: Announced. Sector: pharmaceutical. Target headquarters context: Cairo, Cairo, Egypt.

This page summarizes publicly available information about the transaction as of 2026-01-27. Figures and status may change as filings and press coverage update.

Adenia Partners makes first majority investment in Egypt with acquisition of Parkville Pharmaceuticals 13:40 By CAIRO , Egypt , January 27, 2026 – Adenia Partners , a leading private equity firm focused on growth opportunities in Africa, has signed definitive agreements to acquire a majority stake in Parkville Pharmaceuticals from Admaius Capital Partners , a prominent Africa-focused private equity firm, alongside Dr. Sherif Bassiouny, Chairman of Parkville , and Dr. Mahmoud Farrag, CEO of Parkville